Dual Antiplatelet Therapy

Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) following coronary stenting and in patients with acute coronary syndromes. However, there has been controversy regarding the duration of DAPT with recent studies demonstrating the benefits of prolonging DAPT beyond 12 months.

Which of the following patients is most likely to benefit most from prolonged DAPT?

Show Answer